New Delhi: Amid the ongoing resurgence of new Covid-19 cases in the country, an expert panel of the Central Drugs Standard Control Organisation has approved two new vaccines and one anti-viral drug for restricted use in emergency situation. The CDSCO has granted the Emergency Use Authorization (EUA) to COVOVAX, developed by the Serum Institute of […]
New Delhi: The World Health Organisation on Friday approved emergency use listing of Covid vaccine Covovax, produced by the Serum Institute of India under licence from Novavax and part of the Covax facility portfolio. “This is yet another milestone in our fight against Covid-19. Covovax is now WHO approved for emergency use, showing excellent safety […]
New Delhi: Biological E has received approval for conducting phase II/III human clinical trial of Covid-19 vaccine candidate Corbevax on children above five years and adolescents, Department of Biotechnology (DBT) said on Friday. Corbevax, an RBD protein sub-unit vaccine, has been developed with supported from the Department of Biotechnology and its PSU Biotechnology Industry Research […]
Covovax trials finally begin in India; the vaccine is made through a partnership with Novavax and Serum Institute of India. It has been tested against African and UK variants of COVID19 and has an overall efficacy of 89 per cent.
